抗胆固醇药物负担和发生的心血管事件:基于人口的研究
Nanbo Zhu1, Maria Eriksdotter2,3, Bahira Shahim4
1Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. nanbo.zhu@ki.se.
BMC medicine
|February 27, 2026
概括
对抗胆固醇药物的累积暴露显著增加了45岁以上成年人心血管事件的风险. 较高的药物负担与更大的风险相关,强调谨慎的处方和监测,以确保患者的安全.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 老年病的医生 老年病的医生
背景情况:
- 抗胆固醇药物广泛用于老年人.
- 累积抗胆固醇药物暴露对心血管的长期影响尚不清楚.
- 这项研究调查了抗胆固醇药物负担与心血管事件事件之间的关联.
研究的目的:
- 为了确定累积抗胆固醇药物负担是否与心血管事件风险增加有关.
- 量化抗胆固醇药物暴露和心血管风险之间的剂量反应关系.
- 在老年人群中使用抗胆固醇药物的临床实践中提供信息.
主要方法:
- 一项基于人口的大型队列研究,对508,273名45岁以上的斯德哥尔摩居民进行了研究.
- 使用抗胆固醇认知负担量表和定义的每日剂量 (DDD) 来量化抗胆固醇负担.
- 用逆概率加权的考克斯比例危险模型用于与发生心血管事件的关联分析.
主要成果:
- 较高的抗胆固醇药物暴露显著与心血管事件风险增加有关.
- 观察到一个明确的剂量反应关系,HRs随着累积DDDs的增加而增加.
- 对心力衰竭,心律失常,动脉疾病,静脉血栓栓塞,心肌梗塞和脑血管疾病发现了重要的关联.
结论:
- 累积的抗胆固醇药物负担在中年和老年人中带来潜在的心血管风险.
- 这些发现强调了需要谨慎处方和警监测抗胆固醇药物的需要.
- 这项研究强调了在评估心血管风险时考虑累积药物效应的重要性.
相关概念视频
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.7K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
01:28Cholinergic Antagonists: Pharmacological Actions
1.9K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.9K
01:24Cholinergic Antagonists: Pharmacokinetics
1.0K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.0K
01:26Cholinergic Antagonists: Therapeutic Uses
1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K